Evidence map›Paper›PMID 32094369›Full record

ArticleNature communications2020

Author Correction: MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer.

Yota Yasumizu, Hasan Rajabi, Caining Jin, Tsuyoshi Hata, Sean Pitroda, Mark D Long, Masayuki Hagiwara, Wei Li, Qiang Hu, Song Liu and 13 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Yota YasumizuDana-Farber Cancer Institute Harvard Medical School, Boston, MA, USA.
Hasan RajabiDana-Farber Cancer Institute Harvard Medical School, Boston, MA, USA.
Caining JinDana-Farber Cancer Institute Harvard Medical School, Boston, MA, USA.
Tsuyoshi HataDana-Farber Cancer Institute Harvard Medical School, Boston, MA, USA.
Sean PitrodaDepartment of Radiation and Cellular Oncology, University of Chicago, Chicago, IL, USA.
Mark D LongDepartment of Biostatistics and Bioinformatics Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.ORCID http://orcid.org/0000-0003-1120-8176
Masayuki HagiwaraDana-Farber Cancer Institute Harvard Medical School, Boston, MA, USA.
Wei LiDana-Farber Cancer Institute Harvard Medical School, Boston, MA, USA.
Qiang HuDepartment of Biostatistics and Bioinformatics Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.ORCID http://orcid.org/0000-0002-4090-5539
Song LiuDepartment of Biostatistics and Bioinformatics Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Nami YamashitaDana-Farber Cancer Institute Harvard Medical School, Boston, MA, USA.
Atsushi FushimiDana-Farber Cancer Institute Harvard Medical School, Boston, MA, USA.
Ling KuiDana-Farber Cancer Institute Harvard Medical School, Boston, MA, USA.
Mehmet SamurDana-Farber Cancer Institute Harvard Medical School, Boston, MA, USA.
Masaaki YamamotoDana-Farber Cancer Institute Harvard Medical School, Boston, MA, USA.
Yan ZhangDana-Farber Cancer Institute Harvard Medical School, Boston, MA, USA.
Ning ZhangDana-Farber Cancer Institute Harvard Medical School, Boston, MA, USA.
Deli HongDana-Farber Cancer Institute Harvard Medical School, Boston, MA, USA.
Takahiro MaedaDepartment of Urology, Keio University School of Medicine Shinjuku-ku, Tokyo, Japan.
Takeo KosakaDepartment of Urology, Keio University School of Medicine Shinjuku-ku, Tokyo, Japan.ORCID http://orcid.org/0000-0002-4371-4594
Kwok K WongLaura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA.ORCID http://orcid.org/0000-0001-6323-235X
Mototsugu OyaDepartment of Urology, Keio University School of Medicine Shinjuku-ku, Tokyo, Japan.
Donald KufeDana-Farber Cancer Institute Harvard Medical School, Boston, MA, USA. donald_kufe@dfci.harvard.edu.ORCID http://orcid.org/0000-0001-5743-8888

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID32094369
PMCPMC7039914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.